Zenbiz Lifescience Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 01-06-2024
- Paid Up Capital ₹ 3.00 M
as on 01-06-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 1.00 Cr
as on 01-06-2024
- Revenue %
(FY 2020)
- Profit 7.24%
(FY 2020)
- Ebitda 8.10%
(FY 2020)
- Net Worth -16.41%
(FY 2020)
- Total Assets -15.97%
(FY 2020)
About Zenbiz Lifescience
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹1.00 Cr.
Mrutyunjaya Pattanayak, Ajaya Pattanayak, and Snehasish Das serve as directors at the Company.
- CIN/LLPIN
U51397OR2009PTC011295
- Company No.
011295
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2009
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Zenbiz Lifescience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mrutyunjaya Pattanayak  | Director | 10-Nov-2009 | Current |
| Ajaya Pattanayak | Director | 10-Nov-2009 | Current |
| Snehasish Das | Director | 10-Nov-2009 | Current |
Financial Performance and Corporate Structure Insights of Zenbiz Lifescience.
Zenbiz Lifescience Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 7.24% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenbiz Lifescience?
Unlock access to Zenbiz Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Frazen Pharmaceuticals Private LimitedActive 8 years 4 monthsMrutyunjaya Pattanayak is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Bank Creation Date: 22 Sep 2011 | ₹1.00 Cr | Open |
How Many Employees Work at Zenbiz Lifescience?
Unlock and access historical data on people associated with Zenbiz Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenbiz Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenbiz Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
